Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study Evaluating the Safety, Tolerability and Efficacy of PBT2 in Patients With Early Alzheimer's Disease

This study has been completed.
Information provided by:
Prana Biotechnology Limited Identifier:
First received: May 8, 2007
Last updated: January 13, 2008
Last verified: January 2008